Immuneering IMRX
NASDAQ IMRX
$4.03 -0.06 (-1.59%)
At close: Oct 1, 2026 · 4:00 PM EDT

Immuneering (IMRX) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Immuneering (IMRX) recorded Depreciation & Amortization (CF) of $84,454 in Q2 2026, down 0.1% from $84,527 a year earlier but up 3.7% from the prior quarter.

Analysis

Immuneering (IMRX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

On a TTM basis, Immuneering's Depreciation & Amortization (CF) came in at $320,586 as of Jun 30, 2026, down 7.0% year-over-year; for FY2025, it was $324,517, down 8.8% from FY2024.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of 67.9% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $355,807 in FY2024 (+10.2%), $322,816 in FY2023 (+30.6%), $247,199 in FY2022 (+443.7%) and $45,467 in FY2021 (+86.9%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $11,978 in Q3 2021 to $90,533 in Q2 2024 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined for seven consecutive quarters, with an average decline of 3.8% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 468.3% in Q3 2022, against a decline of 11.9% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $81,402 (Q1 2026), $75,889 (Q4 2025) and $78,841 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Immuneering 264.61 Mn 264.61 Mn - 84,454.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 84,454.00
Mar 31, 2026 81,402.00
Dec 31, 2025 75,889.00
Sep 30, 2025 78,841.00
Jun 30, 2025 84,527.00
Mar 31, 2025 85,261.00
Dec 31, 2024 86,116.00
Sep 30, 2024 88,949.00
Jun 30, 2024 90,533.00
Mar 31, 2024 90,209.00
Dec 31, 2023 89,754.00
Sep 30, 2023 78,294.00
Jun 30, 2023 78,241.00
Mar 31, 2023 76,527.00
Dec 31, 2022 76,862.00
Sep 30, 2022 68,075.00
Jun 30, 2022 54,560.00
Mar 31, 2022 47,704.00
Dec 31, 2021 14,815.00
Sep 30, 2021 11,978.00
API Access

Immuneering Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=IMRX&period=max&api_key=YOUR_API_KEY